Immunis.AI
Royal Oak, Michigan, United States
Developer of a non-invasive blood-based immunogenomic platform discovery platform designed to detect cancer and other diseases that individuals may be harboring and the body's immune response to those diseases The company's platform uses machine learning to perform detailed genomic analysis of patient blood samples to understand diseases by analyzing differential gene expression patterns to characterize the disease and identifies novel biomarkers and biological pathways, thereby helping clinicians and pharmaceutical developers to improve sensitive small tumor profiling that can be used for screening, diagnosis, prognosis, and surveillance.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2019
- Website
- immunis.ai/
Categories
Only accessible to MedStartr community members.
Join nowWhat do you think of Immunis.AI?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now